Blocking GRP78-CD44v Halts Triple-Negative Breast Cancer
In an era where triple-negative breast cancer (TNBC) continues to defy conventional therapeutic strategies, groundbreaking insights into cellular mechanisms offer...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
In an era where triple-negative breast cancer (TNBC) continues to defy conventional therapeutic strategies, groundbreaking insights into cellular mechanisms offer...
In a groundbreaking phase II proof-of-concept clinical trial published recently in Nature Communications, researchers led by Tabata, Huang, and Giudice...
A groundbreaking clinical trial spearheaded by the Alliance for Clinical Trials in Oncology is set to explore transformative treatment strategies...
In the quest to revolutionize cancer treatment, researchers have long grappled with the challenge of delivering potent, yet poorly soluble...
In a landmark development poised to reshape the therapeutic landscape of Ewing sarcoma (ES), the latest findings from the EURO...
In a groundbreaking comparative study presented at the 2026 European Association of Urology Congress in London, researchers have unveiled compelling...
In the ever-evolving landscape of cancer therapy, recent advances have spotlighted pyroptosis, a form of programmed cell death, as a...
In a groundbreaking study poised to reshape our understanding of chemotherapy resistance, researchers have unveiled a novel molecular mechanism driving...
In a groundbreaking development published in the British Journal of Cancer, a team of researchers has employed genomic sequencing techniques...
In the realm of breast cancer care, the timeliness of surgical intervention remains a linchpin for improving patient outcomes. Despite...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine